Extracellular matrix alterations in metastatic processes

M Paolillo, S Schinelli - International journal of molecular sciences, 2019 - mdpi.com
The extracellular matrix (ECM) is a complex network of extracellular-secreted
macromolecules, such as collagen, enzymes and glycoproteins, whose main functions deal …

[HTML][HTML] Caveolin-1 function at the plasma membrane and in intracellular compartments in cancer

L Simón, A Campos, L Leyton, AFG Quest - Cancer and Metastasis …, 2020 - Springer
Abstract Caveolin-1 (CAV1) is commonly considered to function as a cell surface protein, for
instance in the genesis of caveolae. Nonetheless, it is also present in many intracellular …

Identification of CAV1 and DCN as potential predictive biomarkers for lung adenocarcinoma

Y Yan, Z Xu, L Qian, S Zeng, Y Zhou… - … of Physiology-Lung …, 2019 - journals.physiology.org
Lung adenocarcinoma (LUAD) is the most common histological form of lung cancer that is
clinically diagnosed. The aim of this study is to explore the novel genes associated with …

The binomial “inflammation-epigenetics” in breast cancer progression and bone metastasis: IL-1β actions are influenced by TET inhibitor in MCF-7 cell line

D Bellavia, V Costa, A De Luca, A Cordaro… - International Journal of …, 2022 - mdpi.com
The existence of a tight relationship between inflammation and epigenetics that in primary
breast tumor cells can lead to tumor progression and the formation of bone metastases was …

Mitochondrial dysfunction and the glycolytic switch induced by caveolin-1 phosphorylation promote cancer cell migration, invasion, and metastasis

N Díaz-Valdivia, L Simón, J Díaz, S Martinez-Meza… - Cancers, 2022 - mdpi.com
Simple Summary Caveolin-1 (CAV1) is a membrane protein that has been attributed a dual
role in cancer, acting at early stages as a tumor suppressor and in later stages of the …

The screening of immune-related biomarkers for prognosis of lung adenocarcinoma

Z Liu, D Sun, Q Zhu, X Liu - Bioengineered, 2021 - Taylor & Francis
Lung adenocarcinoma (LUAD) accounts for a frequently seen non-small cell lung cancer
(NSCLC) histological subtype, and it is associated with dismal prognostic outcome …

Topoisomerase inhibitors promote cancer cell motility via ROS-mediated activation of JAK2-STAT1-CXCL1 pathway

J Liu, L Qu, L Meng, C Shou - Journal of Experimental & Clinical Cancer …, 2019 - Springer
Background Topoisomerase inhibitors (TI) can inhibit cell proliferation by preventing DNA
replication, stimulating DNA damage and inducing cell cycle arrest. Although these agents …

Caveolae-associated molecules, tumor stroma, and cancer drug resistance: Current findings and future perspectives

JY Low, M Laiho - Cancers, 2022 - mdpi.com
Simple Summary Cell membranes contain small invaginations called caveolae. They are a
specialized lipid domain and orchestrate cellular signaling events, mechanoprotection, and …

The non-receptor tyrosine phosphatase type 14 blocks caveolin-1-enhanced cancer cell metastasis

NI Díaz-Valdivia, J Díaz, P Contreras, A Campos… - Oncogene, 2020 - nature.com
Abstract Caveolin-1 (CAV1) enhanced migration, invasion, and metastasis of cancer cells is
inhibited by co-expression of the glycoprotein E-cadherin. Although the two proteins form a …

[HTML][HTML] Inhibition of glycolysis and Src/Akt signaling reduces Caveolin-1-enhanced metastasis

L Simón, K Torres, P Contreras, N Díaz-Valdivia… - Biomedicine & …, 2024 - Elsevier
Metastasis is the leading cause of cancer-related deaths, making the development of novel,
more effective therapies imperative to alleviate patient suffering. Metabolic switching is a …